02-2024
|
Women’s Ischemia Syndrome Evaluation (WISE) – Mechanisms
Women’s Ischemia Syndrome Evaluation (WISE) – Mechanisms
|
09-2021
|
Women s Ischemia Trial to Reduce Events in Non-Obstructi
Women s Ischemia Trial to Reduce Events in Non-Obstructi
|
05-2021
|
Sex Differences in Chronic and Acute Vascular Responses
Sex Differences in Chronic and Acute Vascular Responses
|
05-2021
|
OR-DRPD-ROF2018: Perfusable Magnetic Cryoprotecting Age
OR-DRPD-ROF2018: Perfusable Magnetic Cryoprotecting Age
|
03-2021
|
ADAPTABLE
ADAPTABLE
|
03-2021
|
Brain-Gut Microbiome-Immune Axis in Hypertension
Brain-Gut Microbiome-Immune Axis in Hypertension
|
08-2020
|
CCTRN-2 Time, Late Time, and Focus
CCTRN-2 Time, Late Time, and Focus
|
08-2020
|
CCTRN-2
CCTRN-2
|
08-2020
|
R-WISE
R-WISE
|
09-2019
|
INVESTED
INVESTED
|
05-2019
|
Angiotensin and neuroimmune activation in hypertension
Angiotensin and neuroimmune activation in hypertension
|
03-2019
|
OneFlorida Clinical Research Consortium Phase II
OneFlorida Clinical Research Consortium Phase II
|
12-2018
|
ATHENA
ATHENA
|
12-2018
|
ODYSSEY
ODYSSEY
|
11-2018
|
The LIFE Study
The LIFE Study
|
08-2018
|
STOP HEART DISEASE--Dr. Qi
STOP HEART DISEASE--Dr. Qi
|
03-2018
|
MI-NSTEMI
MI-NSTEMI
|
07-2017
|
PEAR
PEAR
|
05-2017
|
PRESERVE
PRESERVE
|
03-2017
|
TEVA
TEVA
|
12-2016
|
ALLSTAR
ALLSTAR
|
09-2016
|
A STUDY OF QUINAPRIL IN WOMEN WITH CHEST PAIN, CORONARY
A STUDY OF QUINAPRIL IN WOMEN WITH CHEST PAIN, CORONARY
|
08-2016
|
EFFECT OF SILDENAFIL ON VASCULAR FUNCTION IN WOMEN WITH
EFFECT OF SILDENAFIL ON VASCULAR FUNCTION IN WOMEN WITH
|
06-2016
|
COLOR Registry
COLOR Registry
|
05-2016
|
ATHENA ANCILLARY
ATHENA ANCILLARY
|
04-2016
|
Optimizing Rural Health Clinic Infrastructure to Maximiz
Optimizing Rural Health Clinic Infrastructure to Maximiz
|
03-2016
|
BAXTER CMI--RENEW
BAXTER CMI--RENEW
|
02-2016
|
SOLID-TIMI
SOLID-TIMI
|
10-2015
|
PRESERVATION 1
PRESERVATION 1
|
08-2015
|
WISE CMR
WISE CMR
|
02-2015
|
ATHENA II
ATHENA II
|
12-2014
|
T3SS-Mediated Cardiomyocyte Engineering
T3SS-Mediated Cardiomyocyte Engineering
|
12-2014
|
STABILITY
STABILITY
|
12-2014
|
CTSN/CCTRN LVAD
CTSN/CCTRN LVAD
|
03-2014
|
Abbott Professional Services Agreement
Abbott Professional Services Agreement
|
07-2013
|
Ancillary Functional Studies for the CCTRN
Ancillary Functional Studies for the CCTRN
|
12-2012
|
PRECISION
PRECISION
|
10-2012
|
WISE ACE
WISE ACE
|
02-2012
|
CCTRN Supplement
CCTRN Supplement
|
02-2012
|
CCTRN AMI TIME LATE
CCTRN AMI TIME LATE
|
02-2012
|
UFCC for Cardiovascular Cell Therapy Research Network
UFCC for Cardiovascular Cell Therapy Research Network
|
08-2011
|
LIFE Study - Lifestyle Interventions for the Elderly - S
LIFE Study - Lifestyle Interventions for the Elderly - S
|
06-2011
|
Women s Ischemia Syndrom Evalaution (WISE) Coronary Vasc
Women s Ischemia Syndrom Evalaution (WISE) Coronary Vasc
|
06-2011
|
RESIDUAL CONTINUING MEDICAL EDUCATION
RESIDUAL CONTINUING MEDICAL EDUCATION
|
06-2011
|
MISCELLANEOUS RESIDUAL
MISCELLANEOUS RESIDUAL
|
05-2011
|
BAXTER 34976
BAXTER 34976
|
07-2010
|
MARVEL
MARVEL
|
07-2010
|
WOMEN S ISCHEMIA SYNDROME EVALUATION (WISE) SUB-STUDY-5
WOMEN S ISCHEMIA SYNDROME EVALUATION (WISE) SUB-STUDY-5
|
06-2010
|
WISE Pathophysiology
WISE Pathophysiology
|
04-2010
|
AWARE
AWARE
|
12-2009
|
BAXTER CLI
BAXTER CLI
|
09-2009
|
A MULTI-CTR,RNDMZD,DBL-BL,PLCB-CNTRL STDY TO EVAL THE EF
A MULTI-CTR,RNDMZD,DBL-BL,PLCB-CNTRL STDY TO EVAL THE EF
|
08-2009
|
HYPERTENSION PHARMACOGENETICS
HYPERTENSION PHARMACOGENETICS
|
07-2009
|
BAXTER 24779
BAXTER 24779
|
06-2009
|
FENOFIBRIC ACID M05-749
FENOFIBRIC ACID M05-749
|
06-2009
|
FENOFIBRIC ACID M05-758
FENOFIBRIC ACID M05-758
|
05-2009
|
WISE II
WISE II
|
01-2009
|
VIRON Serp-1-01-002
VIRON Serp-1-01-002
|
11-2007
|
CETP-OP
CETP-OP
|
12-2006
|
ABBOTT INVEST
ABBOTT INVEST
|
12-2006
|
THE INTERNATIONAL VERAPAMIL-TRANDOLAPRIL STUDY (INVEST)
THE INTERNATIONAL VERAPAMIL-TRANDOLAPRIL STUDY (INVEST)
|
12-2006
|
INVEST
INVEST
|
11-2006
|
Heart Disease Outcomes
Heart Disease Outcomes
|
10-2006
|
PILOT STDY TO DETERMINE EFFECT OF CELECOXIB 400MG and 800M
PILOT STDY TO DETERMINE EFFECT OF CELECOXIB 400MG and 800M
|
09-2006
|
FEMHART
FEMHART
|
06-2006
|
HEART DISEASE OUTCOMES:IMPACT OF GENETICS and PHARMACOGENE
HEART DISEASE OUTCOMES:IMPACT OF GENETICS and PHARMACOGENE
|
12-2005
|
INVEST
INVEST
|
08-2005
|
BETA-BLOCKER PHARMACOGENETICS IN ETHNIC POPULATION: A SU
BETA-BLOCKER PHARMACOGENETICS IN ETHNIC POPULATION: A SU
|
06-2005
|
DIVISION RESIDUAL ACCOUNT
DIVISION RESIDUAL ACCOUNT
|
06-2005
|
HEART DISEASE OUTCOMES:IMPACT OF GENETICS and PHARMACOGENE
HEART DISEASE OUTCOMES:IMPACT OF GENETICS and PHARMACOGENE
|
05-2005
|
RENIN ANGIOSTENSIN FOR CORONARY MICROVASCULAR DYSFUNCTIO
RENIN ANGIOSTENSIN FOR CORONARY MICROVASCULAR DYSFUNCTIO
|
06-2004
|
TNT
TNT
|
09-2003
|
LOVENOX IN ATRIAL FIBRILLATION
LOVENOX IN ATRIAL FIBRILLATION
|
07-2003
|
RNDMZED,DBL-BLND,PLACEBO-CNTRLLED,PARALELL GROUP,COMPARA
RNDMZED,DBL-BLND,PLACEBO-CNTRLLED,PARALELL GROUP,COMPARA
|
12-2002
|
GENETICS DATABASE OF INVEST POPULATION; GENETICS AND
GENETICS DATABASE OF INVEST POPULATION; GENETICS AND
|
06-2002
|
STUDY OF THE CHRONIC ADMINISTRATION OF OPC-8212
STUDY OF THE CHRONIC ADMINISTRATION OF OPC-8212
|
05-2002
|
ALTERED RENIN ANGIOSTENSIN SYSTEM AS MECHANISM FOR CORON
ALTERED RENIN ANGIOSTENSIN SYSTEM AS MECHANISM FOR CORON
|
02-2002
|
CARISA: (CTV-3033) A DBL-BL RANDOMIZED STRATIFIED PLCB-C
CARISA: (CTV-3033) A DBL-BL RANDOMIZED STRATIFIED PLCB-C
|
01-2002
|
A PHASE III DBL-BL EFFIC and SAF STDY OF SCH 58235 (10MG)
A PHASE III DBL-BL EFFIC and SAF STDY OF SCH 58235 (10MG)
|
04-2001
|
XANADU
XANADU
|
02-2001
|
(QUASAR) A 16 WK, DBL-BL, PLCB-CNTRL, PRLEL GROUP STUDY
(QUASAR) A 16 WK, DBL-BL, PLCB-CNTRL, PRLEL GROUP STUDY
|
06-2000
|
NATRECOR VS DOBUTAMINE
NATRECOR VS DOBUTAMINE
|
06-2000
|
MYOCARDIAL ISCHEMIA REDUCTION WITH AGGRESSIVE CHOLESTERO
MYOCARDIAL ISCHEMIA REDUCTION WITH AGGRESSIVE CHOLESTERO
|
06-2000
|
RANOLAZINE CVT 3031
RANOLAZINE CVT 3031
|
06-2000
|
OTSUKA 96-201
OTSUKA 96-201
|
06-2000
|
IMPRESS TRIAL
IMPRESS TRIAL
|
06-2000
|
BMS 013
BMS 013
|
06-2000
|
STUDY OF CHRONIC EFFICACY and SAFETY OF OPC-18790 FOR THE
STUDY OF CHRONIC EFFICACY and SAFETY OF OPC-18790 FOR THE
|
06-2000
|
STUDY OF INTERMITTENT INTRAVENOUS MILRINONE THERAPY IN T
STUDY OF INTERMITTENT INTRAVENOUS MILRINONE THERAPY IN T
|
06-2000
|
OTSUKA 202
OTSUKA 202
|
06-2000
|
STARS
STARS
|
06-2000
|
NATRECOR
NATRECOR
|
06-2000
|
SANOFI ACT 2401
SANOFI ACT 2401
|
06-2000
|
ZOPLORESTAT
ZOPLORESTAT
|
06-2000
|
VEST
VEST
|
06-2000
|
ADOSE-RANGING OF FDP ON HEMODYNAMICS IN PATIENTS WITH
ADOSE-RANGING OF FDP ON HEMODYNAMICS IN PATIENTS WITH
|
06-2000
|
THE EFFECT OF RO 40-5967 ON ALL CUASES OF MORTALITY IN C
THE EFFECT OF RO 40-5967 ON ALL CUASES OF MORTALITY IN C
|
03-2000
|
RANOLAZINE CVT 3032
RANOLAZINE CVT 3032
|
02-2000
|
A TRIAL TO INVESTIGATE THE COMPARATIVE EFFICACY and SAFETY
A TRIAL TO INVESTIGATE THE COMPARATIVE EFFICACY and SAFETY
|
01-2000
|
BETA BLOCKER EVALUATION OF SURVIVAL TRIAL
BETA BLOCKER EVALUATION OF SURVIVAL TRIAL
|
10-1999
|
EVALUATION OF THE EFFICACY and SAFETY OF OPC-18790 IN THE
EVALUATION OF THE EFFICACY and SAFETY OF OPC-18790 IN THE
|
08-1999
|
ACIP 001
ACIP 001
|
07-1999
|
GENSIA
GENSIA
|
06-1999
|
NOVA - SALARY FUNDS
NOVA - SALARY FUNDS
|
06-1999
|
STUDY COMPARING AGGRESSIVE LIPID LOWERING WITH ATORVASTA
STUDY COMPARING AGGRESSIVE LIPID LOWERING WITH ATORVASTA
|
06-1999
|
TREND
TREND
|
06-1999
|
SCAI BRACCO
SCAI BRACCO
|
06-1999
|
STUDY TO INVESTIGATE THE SAFETY and CLINICAL OF EFFICACY O
STUDY TO INVESTIGATE THE SAFETY and CLINICAL OF EFFICACY O
|
06-1999
|
BMS EXERCISE
BMS EXERCISE
|
05-1999
|
STUDY OF ESCALATING MULTIPLE DOSES OF DMP754 IN PATIENTS
STUDY OF ESCALATING MULTIPLE DOSES OF DMP754 IN PATIENTS
|
12-1998
|
BMS IBERSARTAN
BMS IBERSARTAN
|
12-1998
|
COMPARISON OF THE ANTISCHEMIC ACTIVITY OF ORAL MS 180291
COMPARISON OF THE ANTISCHEMIC ACTIVITY OF ORAL MS 180291
|
10-1998
|
EVALUATE THE EFFECT OF QUINAPRIL IN REDUCING ISCHEMIC
EVALUATE THE EFFECT OF QUINAPRIL IN REDUCING ISCHEMIC
|
06-1998
|
LONG TERM HEMODYNAMIC EFFECTS.....METALLOPROTEASE INHIBI
LONG TERM HEMODYNAMIC EFFECTS.....METALLOPROTEASE INHIBI
|
06-1998
|
PLACEBO CONTROLLED SINGLE DOSE CROSS-OVER TRIAL TO EVALU
PLACEBO CONTROLLED SINGLE DOSE CROSS-OVER TRIAL TO EVALU
|
06-1998
|
EVALUATE THE SAFETY and HEMODYNAMIC EFFECTS OF SINGLE ORAL
EVALUATE THE SAFETY and HEMODYNAMIC EFFECTS OF SINGLE ORAL
|
06-1998
|
SIGMA TAU SALARY FUNDS
SIGMA TAU SALARY FUNDS
|
06-1998
|
BIOGEN
BIOGEN
|
06-1998
|
NTG
NTG
|
06-1998
|
RANOLAZINE
RANOLAZINE
|
06-1998
|
PROVISION OF SALARY FUNDS
PROVISION OF SALARY FUNDS
|
08-1997
|
EVALUATION OF ISCHEMIC HEART DISEASE IN WOMEN - CLINICA
EVALUATION OF ISCHEMIC HEART DISEASE IN WOMEN - CLINICA
|